Literature DB >> 10823594

Does early treatment by abduction splintage improve the development of dysplastic but stable neonatal hips?

M K Wood1, V Conboy, M K Benson.   

Abstract

A prospective trial was carried out to assess the outcome of children aged from 2 to 6 weeks with stable but dysplastic hips, treated with abduction splintage or by observation. Forty-four patients with 63 dysplastic hips were entered into the study and allocated into the two treatment groups at random. The ultrasound measured percentage acetabular cover in the splinted group improved in the first 3 months from an average of 32.8 to 54.3%. In the unsplinted group, the increase in cover was from 36.7 to 48.6%. The changes in cover for the splinted group were significantly more than those for the unsplinted group (p < 0.003) There was, however, no significant difference between the two groups in acetabular angle measurements on plain radiographs taken at 3 months. At 24 months, similarly, there was no significant difference in the acetabular angles of the two groups. These results support the view that stable dysplastic hips will correct with growth and that there is no sustained benefit from early splintage.

Entities:  

Mesh:

Year:  2000        PMID: 10823594

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  13 in total

1.  Is DDH still a problem?

Authors:  Reinhard Graf
Journal:  Arch Bone Jt Surg       Date:  2014-03

2.  Asymmetrical thigh creases or isolated thigh crease may be a false positive sign with low predictive value in the diagnosis of developmental dysplasia of the hip in infants: a prospective cohort study of 117 patients.

Authors:  Panagiotis Touzopoulos; Nikolaos G Markeas
Journal:  Eur J Orthop Surg Traumatol       Date:  2019-08-12

Review 3.  Splinting for the non-operative management of developmental dysplasia of the hip (DDH) in children under six months of age.

Authors:  Kerry Dwan; Jamie Kirkham; Robin W Paton; Emma Morley; Ashley William Newton; Daniel C Perry
Journal:  Cochrane Database Syst Rev       Date:  2022-10-10

Review 4.  Treatment of centered developmental dysplasia of the hip under the age of 1 year: an evidence-based clinical practice guideline - Part 1.

Authors:  Christiaan J A van Bergen; Pieter Bas de Witte; Floor Willeboordse; Babette L de Geest; Magritha Margret M H P Foreman-van Drongelen; Bart J Burger; Yvon M den Hartog; Joost H van Linge; Renske M Pereboom; Simon G F Robben; M Adhiambo Witlox; Melinda M E H Witbreuk
Journal:  EFORT Open Rev       Date:  2022-07-05

5.  Performance, treatment pathways, and effects of alternative policy options for screening for developmental dysplasia of the hip in the United Kingdom.

Authors:  C Dezateux; J Brown; R Arthur; J Karnon; A Parnaby
Journal:  Arch Dis Child       Date:  2003-09       Impact factor: 3.791

6.  Efficiency of alternative policy options for screening for developmental dysplasia of the hip in the United Kingdom.

Authors:  J Brown; C Dezateux; J Karnon; A Parnaby; R Arthur
Journal:  Arch Dis Child       Date:  2003-09       Impact factor: 3.791

7.  Influence of the treatment of developmental dysplasia of the hip by the abduction brace on locomotor development in children.

Authors:  Marcin Zgoda; Piotr Wasilewski; Iwona Wasilewska; Dominik Golicki
Journal:  J Child Orthop       Date:  2009-11-24       Impact factor: 1.548

Review 8.  Ultrasonography in developmental dysplasia of the hip: what have we learned?

Authors:  Jennifer Bracken; Michael Ditchfield
Journal:  Pediatr Radiol       Date:  2012-09-02

Review 9.  Ultrasound in the diagnosis of developmental dysplasia of the hip in newborns. The European approach. A review of methods, accuracy and clinical validity.

Authors:  Karen Rosendahl; Paolo Toma
Journal:  Eur Radiol       Date:  2007-01-18       Impact factor: 7.034

10.  Acetabular dysplasia at the age of 1 year in children with neonatal instability of the hip.

Authors:  Daniel Wenger; Henrik Düppe; Carl-Johan Tiderius
Journal:  Acta Orthop       Date:  2013-10-31       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.